CPIG
ALDX icon

Chicago Partners Investment Group’s Aldeyra Therapeutics ALDX Stock Holding History

Chicago Partners Investment Group’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
83,984
+64,461
+330% +$111K ﹤0.01% 1464
2026
Q1 		$33.2K Buy
+19,523
New +$85.5K ﹤0.01% 1439

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Chicago Partners Investment Group's ALDX Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Aldeyra Therapeutics (ALDX) stake by 330% in Q2 2026, buying an estimated $111K and bringing the position to 83,984 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

Chicago Partners Investment Group first reported a position in ALDX in Q1 2026 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Chicago Partners Investment Group held 83,984 shares of Aldeyra Therapeutics worth $130K as of Q2 2026.
  • Chicago Partners Investment Group bought 64,461 Aldeyra Therapeutics shares in Q2 2026, an estimated $111K.
  • Aldeyra Therapeutics made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1464 holding.
  • Chicago Partners Investment Group first reported a position in Aldeyra Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.